RASSF1A is involved in a variety of cellular pathways, and is the most commonly silenced TSG in human cancers (Agathanggelou et al., 2005) and the demonstration of placenta-specific methylation was the first identification of TSG silencing through hypermethylation in any non-cancerous tissue. Here, RASSF1 is linked to cancer.